These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 27784018

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
    Zenzmaier C, Kern J, Heitz M, Plas E, Zwerschke W, Mattesich M, Sandner P, Berger P.
    Exp Cell Res; 2015 Nov 01; 338(2):162-9. PubMed ID: 26410556
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators.
    Sandner P.
    Biol Chem; 2018 Jun 27; 399(7):679-690. PubMed ID: 29604206
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Soluble Guanylate Cyclase Stimulators and Activators: Where are We and Where to Go?
    Xiao S, Li Q, Hu L, Yu Z, Yang J, Chang Q, Chen Z, Hu G.
    Mini Rev Med Chem; 2019 Jun 27; 19(18):1544-1557. PubMed ID: 31362687
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Soluble Guanylate Cyclase: A New Therapeutic Target for Fibrotic Diseases.
    Hu L, Wang Z, Yi R, Yi H, Xiao S, Chen Z, Hu G, Li Q.
    Curr Med Chem; 2017 Jun 27; 24(29):3203-3215. PubMed ID: 28486921
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeted Delivery of Soluble Guanylate Cyclase (sGC) Activator Cinaciguat to Renal Mesangial Cells via Virus-Mimetic Nanoparticles Potentiates Anti-Fibrotic Effects by cGMP-Mediated Suppression of the TGF-β Pathway.
    Fleischmann D, Harloff M, Maslanka Figueroa S, Schlossmann J, Goepferich A.
    Int J Mol Sci; 2021 Mar 04; 22(5):. PubMed ID: 33806499
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D, Galuppo P, Motschenbacher S, Ruetten H, Schäfer A, Bauersachs J.
    Basic Res Cardiol; 2014 Jul 04; 109(4):421. PubMed ID: 24907870
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.